COVID-19 Vaccine Hesitancy An Opening For New Trial, US FDA’s Califf Says In Farewell

 
• By Michael McCaughan
  
Califf wrote that a new CBER analysis confirmed the benefit of the COVID-19 vaccine and boosters.

More from Vaccines

More from R&D